|
Volumn 99, Issue 3, 2016, Pages 265-268
|
The FDAs sentinel initiative A comprehensive approach to medical product surveillance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DABIGATRAN;
INFLUENZA VACCINE;
OLMESARTAN;
ROTAVIRUS VACCINE;
CLINICAL ASSESSMENT;
DRUG SAFETY;
DRUG SCREENING;
DRUG SURVEILLANCE PROGRAM;
ELECTRONIC MEDICAL RECORD;
EVIDENCE BASED MEDICINE;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE SYSTEM;
HEALTH SURVEY;
HUMAN;
METHODOLOGY;
OUTCOME ASSESSMENT;
PATIENT CARE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
REVIEW;
SENTINEL SYSTEM;
ADVERSE EFFECTS;
DEVICES;
LEGISLATION AND JURISPRUDENCE;
POSTMARKETING SURVEILLANCE;
STANDARDS;
UNITED STATES;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
EQUIPMENT AND SUPPLIES;
HUMANS;
PHARMACOVIGILANCE;
PRODUCT SURVEILLANCE, POSTMARKETING;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84958877160
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1002/cpt.320 Document Type: Review |
Times cited : (185)
|
References (10)
|